EMERGENT BIOSOLUTIONS INC's ticker is and the CUSIP is 29089QAB1. A total of 24 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,634,000 | +256.0% | 1,268,000 | +238.1% | 0.00% | – |
Q3 2016 | $459,000 | +18.0% | 375,000 | +9.0% | 0.00% | – |
Q2 2016 | $389,000 | +301.0% | 344,000 | +358.7% | 0.00% | – |
Q1 2016 | $97,000 | -80.8% | 75,000 | -79.5% | 0.00% | – |
Q4 2015 | $504,000 | -76.7% | 366,000 | -80.4% | 0.00% | -100.0% |
Q1 2015 | $2,159,000 | – | 1,868,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 32,141,000 | $41,558,000 | 1.75% |
Wellesley Asset Management | 10,859 | $14,049,000 | 0.73% |
Opera Trading Capital | 2,300,000 | $2,904,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 4,300,000 | $5,543,000 | 0.49% |
WOLVERINE ASSET MANAGEMENT LLC | 25,653,000 | $33,152,000 | 0.42% |
AQR Arbitrage LLC | 29,400,000 | $38,036,000 | 0.42% |
Calamos Advisors LLC | 35,781,000 | $46,261,000 | 0.34% |
CSS LLC/IL | 2,500,000 | $3,228,000 | 0.16% |
ADVENT CAPITAL MANAGEMENT /DE/ | 3,126,000 | $4,043,000 | 0.08% |
D. E. Shaw & Co., Inc. | 22,500,000 | $29,107,000 | 0.05% |